ACE2 and infection: Pharmacological ACE inhibitors such as lisinopril are not effective in reducing ACE2 expression and at only 42% homology between the two enzymes, which can be inferred from their opposing physiological function, ACE inhibitors are not competitive enough at the ACE-2 attachment site with the SARS-CoV-2 to prevent infection [48].